Maetzel Andreas Insider Trades

Insider Trading History

Track insider trading activity for Maetzel Andreas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President, Medical
Holding Value $674k 25,000 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$649k 25,000 shares
$25.95
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President, Medical
Holding Value $1.1M 40,886 shares
Last Trade
Apr 27, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.88M 75,174 shares
$25.06
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President, Medical
Holding Value $687k 25,507 shares
Last Trade
Apr 27, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.93M 76,506 shares
$25.21
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President, Medical
Holding Value $270k 10,000 shares
Last Trade
Feb 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$152k 10,000 shares
$15.21
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President, Medical
Holding Value $539k 20,000 shares
Last Trade
Dec 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$373k 20,000 shares
$18.65
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President Medical
Holding Value $243k 9,000 shares
Last Trade
May 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 9,000 shares
$24.23
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President Medical
Holding Value $1.62M 60,000 shares
Last Trade
Apr 05, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$152k 5,000 shares
$30.41
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President Medical
Holding Value $135k 5,000 shares
Last Trade
Apr 05, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$152k 5,000 shares
$30.41
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President Medical
Holding Value $0 0 shares
Last Trade
Apr 05, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$150k 5,000 shares
$30.00
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President Medical
Holding Value $558k 20,700 shares
Last Trade
Sep 18, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$333k 20,700 shares
$16.08
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President Medical
Holding Value $558k 20,700 shares
Last Trade
Jun 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 20,700 shares
$8.21
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vice President Medical
Holding Value $1.75M 65,000 shares
Last Trade
Mar 08, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$514k 65,000 shares
$7.91
$26.95
Cortexyme
Cortexyme CRTX
Vp, Clinical And Regulatory
Holding Value $0 0 shares
Last Trade
Feb 03, 2014 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$1.95
Cortexyme
Cortexyme CRTX
Vp, Clinical And Regulatory
Holding Value $48.8k 25,000 shares
Last Trade
May 06, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up